| HOME >> MEDICINE >> TECHNOLOGY |
18,721,590Commitments and contingencies-
-Stockholders' equity:Common stock, par value $0.001 per share; authorized 247,500,000, issued and outstanding September 30, 2010 – 23,950,740 shares; September 30, 2009 – 22,363,740 shares (restated to reflect 2 for 1 reverse stock split) 23,951
22,364Additional paid-in capital40,154,494
31,166,123Retained earnings48,730,034
36,797,172Statutory reserves4,585,731
3,428,095Accumulated other comprehensive income 12,302,762
10,717,850Total Winner Medical Group Inc. stockholders' equity105,796,972
82,131,604Non-controlling interests100,199
82,815Total equity105,897,171
82,214,419Total liabilities and equity118,975,995
100,936,009Winner Medical Group Inc.Non-GAAP ReconciliationSeptember 30,20102009US$US$Net income attributable to Winner Medical Group Inc. (GAAP)13,090,497
9,128,745Share-based compensation695,758
300,433Adjusted net income attributable to Winner Medical Group Inc. (Non-GAAP)13,786,254
9,429,007Earnings per share (GAAP)- Basic0.57
0.41- Diluted 0.56
0.41Adjusted earnings per share (Non-GAAP)- Basic 0.60
0.42- Diluted 0.59
0.42Weighted average ordinary shares outstanding- Basic 23,014,065
22,363,675- Diluted 23,383,532
22,403,237September 30,20102009US$US$Selling, general and administrative expenses (GAAP)20,370,949
16,874,131Share-based compensation695,758
300,433Adjusted selling, general and administrative expenses (Non-GAAP)19,675,191
16,573,698
'/>"/>
| SOURCE Winner Medical Group Inc. Copyright©2010 PR Newswire. All rights reserved |